MedTrace Logo

Effects of Omega 3 in Hemodialysis Patients

NCT00431899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2016-03-03

No results posted yet for this study

Summary

The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Conditions

Interventions

BEHAVIORAL

fish oil supplementation

Sponsors & Collaborators

  • Laboratoire Régional de Nutrition Humaine

    lead OTHER

Principal Investigators

  • Jacques Delarue, MD,PhD · CHU Cavale Blanche F-29200 Brest

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Completion
2003-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00431899 on ClinicalTrials.gov